COMP <GO>
APYX vs KRMD // PIOTROSKI F-SCORE QUALITY
Apyx Medical Corporation (NASDAQ) VS. KORU Medical Systems Inc. (NASDAQ) • 15-METRIC TALLY: APYX 2
— KRMD 8
▲ PIOTROSKI F-SCORE QUALITY LEADER: KRMD
LAST: $2.60 (0.00%) • MKT CAP: $109.5M
piotroski-score
5/9
LAST: $3.05 (+2.01%) • MKT CAP: $138.1M
piotroski-score
7/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (APYX VS. KRMD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | APYX | KRMD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 62.50% | 62.30% | +0.20 | APYX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -28.90% | -28.70% | -0.20 | KRMD | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -8.04% | 0.31% | -8.35 | KRMD | /fcf-yield <GO> |
| Operating Margin | -12.20% | -7.20% | -5.00 | KRMD | /operating-margins <GO> |
| Net Profit Margin | -21.20% | -6.40% | -14.80 | KRMD | /net-margins <GO> |
| Revenue Growth (YoY) | 9.90% | 22.20% | -12.30 | KRMD | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.75 | 8.05 | -7.30 | KRMD | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 5/9 | 7/9 | -2.00 | KRMD | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.2 | 44.5 | +4.70 | APYX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $109.5M | $138.1M | -$28.5M | KRMD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | APYX REV | KRMD REV | APYX GROSS % | KRMD GROSS % | APYX FCF | KRMD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $52.8M | $41.1M | 62.5% | 62.3% | -$9.1M | $462.4K |
| FY 2024 | $48.1M | $33.6M | 61.0% | 63.4% | -$18.8M | -$319.7K |
| FY 2023 | $52.3M | $28.5M | — | — | -$5.2M | -$4.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
APYX // BETA —
KRMD // BETA —